What Is a Psilocybin Mushroom? An Australian Guide

Psilocybin mushrooms are fungi that contain the psychoactive compound psilocybin. People often call them “magic mushrooms” or “shrooms.” When you ingest them, your body converts psilocybin into psilocin. This chemical produces hallucinogenic effects. These effects can include altered perception of time and emotions. They can also cause changes in thinking, visual hallucinations, and auditory hallucinations. This guide provides an overview of what psilocybin mushrooms are. It also covers their legal status in Australia. Finally, it explains the emerging medical applications of psilocybin under Australian law.

The Fungus and Its Effects

Psilocybin mushrooms are psychedelic drugs. They can profoundly affect a person’s senses, consciousness, and mood. They produce their effects by temporarily disrupting normal communication pathways in the brain. Consequently, this disruption can lead to the formation of new connections between different neural networks. While over 200 species of psilocybin-producing mushrooms exist worldwide, Australia has between 20 to 30 identified species. Common types found in Australia include “golden tops” (Psilocybe cubensis), “blue meanies” (Copelandia cyanescens), and “liberty caps.”

The Legal Status of Psilocybin Mushrooms in Australia

In a landmark 2023 decision, Australia became the first country to reclassify psilocybin as a medicine for specific therapeutic uses. Nevertheless, the legal status is complex and depends entirely on the purpose of use.

The Therapeutic Exception (Schedule 8)
Since July 1, 2023, the Therapeutic Goods Administration (TGA) has permitted the prescribing of psilocybin for treatment-resistant depression (TRD). For this specific use, psilocybin is a Schedule 8 (Controlled Drug) medicine. However, only authorised psychiatrists can prescribe it. To gain authorisation, the psychiatrist must apply to the TGA under the Authorised Prescriber scheme. Their treatment protocol must also receive approval from a Human Research Ethics Committee (HREC).

General Prohibition (Schedule 9)
For all other purposes, including recreational or general use, psilocybin remains a Schedule 9 (Prohibited Substance). Consequently, possessing, using, or buying psilocybin mushrooms outside the strict medical framework is illegal. These offences carry severe penalties, including fines and imprisonment.

The Legal Medical Pathway

The only way to legally access psilocybin in Australia is through the TGA’s Authorised Prescriber scheme. This pathway is rigorous and designed for patient safety. It does not allow patients to simply walk into a pharmacy or clinic to purchase the substance.

Who Can Prescribe?
Only psychiatrists can prescribe psilocybin. They must hold specialist registration with the Medical Board of Australia. They must also be a Fellow of the Royal Australian and New Zealand College of Psychiatrists (RANZCP). Furthermore, they must receive specific TGA authorisation for each substance. As of mid-2026, about 40 psychiatrists hold such approvals.

Who Can Receive Treatment?
The treatment is currently reserved for patients with treatment-resistant depression. These patients must have not responded to other therapies. The Authorised Prescriber psychiatrist is responsible for patient screening and obtaining informed consent.

How Is Treatment Delivered?
Psilocybin is not a take-home medication. The psychiatrist administers it as part of Psychedelic-Assisted Psychotherapy (PAP) in a medically supervised setting. The psychiatrist must remain present during the treatment session. The treatment occurs in a controlled healthcare environment with established patient monitoring procedures. Consequently, patients cannot take the medicine home.

Numbers, Costs, and Safety

While the legal pathway exists, the uptake is currently limited. As of mid-2026, about 164 patients have received MDMA-assisted therapy. Only 74 patients have received psilocybin therapy outside of clinical trials. The treatment is expensive. At one Perth clinic, a course of psilocybin therapy costs about $20,000. MDMA treatment costs about $30,000. Nevertheless, some coverage is expanding. Medibank Private began funding some aspects of the therapy in 2025. The Department of Veterans’ Affairs (DVA) is also providing access to eligible veterans.

The safety profile in this controlled medical setting appears promising. One psychiatrist involved in the program reported that the only adverse effects seen have been mild and self-limiting. However, experts caution that the treatments are not suitable for everyone. They should only occur under medical supervision due to risks such as nausea, vomiting, and potential cardiac issues.

Conclusion

A psilocybin mushroom is a naturally occurring fungus that contains the psychoactive compound psilocybin. In Australia, it is illegal to possess, use, or forage for these mushrooms for general purposes. The only legal access is through a strict medical pathway for treatment-resistant depression. An authorised psychiatrist administers it in a controlled clinical setting as part of psychedelic-assisted psychotherapy. This guide is for educational and research purposes only. It does not constitute legal advice. If you are considering psilocybin for a mental health condition, the only path forward is through discussion with a General Practitioner and a suitably qualified psychiatrist..